<html><head><title>ulf meier patients</title>
<meta http-equiv="Content-Type" content="text/html">
<meta http-equiv="Author" name="ulf meier" content="patients">
<meta http-equiv="Author" name="patients" content="patients">
<meta name="Language" content="de-en">
<meta name="Keywords" lang="de" content="patients, ulf meier, patients">
<meta name="Keywords" lang="en" content="ulf meier, patients, , patients">
<meta name="Description" lang=" "content="">
<meta name="Revisit-after" content="1 month">
<meta name="Date_modified" content="2001-06-14">
<meta name="ROBOTS" content="index,follow">
</head>
<style type="text/css"> 
	A.nav:link {TEXT-DECORATION: none}
	A.nav:visited {TEXT-DECORATION: none} 
	A.nav:visited {TEXT-DECORATION: none}
	A.nav:active {TEXT-DECORATION: none}
	A.nav:hover {TEXT-DECORATION: none}
	</style><body bgcolor="#FFFFF">
	<font face="arial" size="3" color="#000000">
	<table border="0" cellpadding="0" cellspacing="0" width="100%">
	<tr><td><a href="patients.html" class="nav">patients</a></td></tr>
	<tr><td><a href="index.html" class="nav">home page</a></td></tr></table>
	<br><div align="center"><font size="6">- patients -<br><br></font></div>
<table width="100%" border="0" cellspacing="3" cellpadding="0"
<td valign="center">
</td>
<td valign="top"><img height="268" width="236" src="http://www.felinecrf.com/images/av2000d.jpg"></td>
<tr>
</table>
<table width="100%" border="0" cellspacing="3" cellpadding="5">
<td valign="bottom">
</td>
<tr>
</table>
<table width="100%" border="0" cellspacing="1" cellpadding="6"
<td valign="center">
</td>
<td valign="center"><img height="298" width="400" src="http://www.vetmed.wsu.edu/boeing/small_animal_medicine/images/fat2.jpg"></td>
<tr>
</table>
<table width="100%" border="0" cellspacing="1" cellpadding="4">
<td valign="bottom"><img height="440" width="373" src="http://www.vetmed.wsu.edu/boeing/small_animal_medicine/images/calcitriol3.jpg"></td>
<td valign="top">
 . A new study answers a six-year question over long-term advantages from a new form of cyclosporine. CDT May 14 Kidney transplant patients fare better over the long term with newer form of "gold standard" drug, study finds ANN ARBOR, MI - A reformulation of the "gold standard" drug against kidney transplant rejection not only costs less and gets absorbed better - it also helps transplant recipients keep their new organs longer. Patients who took the microemulsion form of the drug, introduced in 1995, had a significantly lower risk of suffering chronic failure of their transplanted kidney than those who used the older form of the same drug. The results, from one of the largest studies of its kind, will be presented May 14 in Chicago at Transplant 2001, the annual meeting of the American Society of Transplantation.</td>
<tr>
</table>
<br>A good patients site: <a href="http://www.vetinfo.com/linkpage.html">http://www.vetinfo.com/linkpage.html</a><br><br>
</font><font size=-6> <a class="nav" href="">.</a><br><br>
</font></body></html>
